<?xml version="1.0" encoding="utf-8" standalone="no"?>
<billStatus>
  <version>3.0.0</version>
  <bill>
    <number>4866</number>
    <updateDate>2023-01-11T13:45:07Z</updateDate>
    <updateDateIncludingText>2023-01-11T13:45:07Z</updateDateIncludingText>
    <originChamber>House</originChamber>
    <type>HR</type>
    <introducedDate>2019-10-28</introducedDate>
    <congress>116</congress>
    <constitutionalAuthorityStatementText><![CDATA[<pre>[Congressional Record Volume 165, Number 170 (Monday, October 28, 2019)][House]From the Congressional Record Online through the Government Publishing Office [<a href="http://www.gpo.gov">www.gpo.gov</a>]By Mr. PALLONE:H.R. 4866.Congress has the power to enact this legislation pursuantto the following:Article 1, Section 8, Clause 3, ``To regulate commerce withforeign nations, and among the several states, and with theIndian tribes''[Page H8539]</pre>]]></constitutionalAuthorityStatementText>
    <committees>
      <item>
        <systemCode>sshr00</systemCode>
        <name>Health, Education, Labor, and Pensions Committee</name>
        <chamber>Senate</chamber>
        <type>Standing</type>
        <activities>
          <item>
            <name>Referred to</name>
            <date>2020-09-22T22:37:11Z</date>
          </item>
        </activities>
      </item>
      <item>
        <systemCode>hsif00</systemCode>
        <name>Energy and Commerce Committee</name>
        <chamber>House</chamber>
        <type>Standing</type>
        <subcommittees>
          <item>
            <systemCode>hsif14</systemCode>
            <name>Health Subcommittee</name>
            <activities>
              <item>
                <name>Reported by</name>
                <date>2020-03-11T14:06:16Z</date>
              </item>
              <item>
                <name>Markup by</name>
                <date>2020-03-11T13:55:24Z</date>
              </item>
              <item>
                <name>Referred to</name>
                <date>2019-10-29T18:26:21Z</date>
              </item>
            </activities>
          </item>
        </subcommittees>
        <activities>
          <item>
            <name>Reported by</name>
            <date>2020-09-17T17:26:30Z</date>
          </item>
          <item>
            <name>Markup by</name>
            <date>2020-07-15T13:26:01Z</date>
          </item>
          <item>
            <name>Referred to</name>
            <date>2019-10-28T16:00:50Z</date>
          </item>
        </activities>
      </item>
    </committees>
    <committeeReports>
      <committeeReport>
        <citation>H. Rept. 116-513</citation>
      </committeeReport>
    </committeeReports>
    <relatedBills>
      <item>
        <title>Workforce Emergency Response Act of 2020</title>
        <congress>116</congress>
        <number>6379</number>
        <type>HR</type>
        <latestAction>
          <actionDate>2020-03-23</actionDate>
          <text>Referred to the Committee on Appropriations, and in addition to the Committees on the Budget, and Ways and Means, for a period to be subsequently determined by the Speaker, in each case for consideration of such provisions as fall within the jurisdiction of the committee concerned.</text>
        </latestAction>
        <relationshipDetails>
          <item>
            <type>Related bill</type>
            <identifiedBy>CRS</identifiedBy>
          </item>
        </relationshipDetails>
      </item>
      <item>
        <title>The Heroes Act</title>
        <congress>116</congress>
        <number>6800</number>
        <type>HR</type>
        <latestAction>
          <actionDate>2020-07-23</actionDate>
          <text>Committee on Small Business and Entrepreneurship. Hearings held.</text>
        </latestAction>
        <relationshipDetails>
          <item>
            <type>Related bill</type>
            <identifiedBy>CRS</identifiedBy>
          </item>
        </relationshipDetails>
      </item>
      <item>
        <title>Commitment to Defeat the Virus and Keep America Healthy Act</title>
        <congress>116</congress>
        <number>14</number>
        <type>HR</type>
        <latestAction>
          <actionDate>2020-11-02</actionDate>
          <text>Referred to the Subcommittee on Railroads, Pipelines, and Hazardous Materials.</text>
        </latestAction>
        <relationshipDetails>
          <item>
            <type>Related bill</type>
            <identifiedBy>CRS</identifiedBy>
          </item>
        </relationshipDetails>
      </item>
    </relatedBills>
    <actions>
      <item>
        <actionDate>2020-09-22</actionDate>
        <committees>
          <item>
            <systemCode>sshr00</systemCode>
            <name>Health, Education, Labor, and Pensions Committee</name>
          </item>
        </committees>
        <sourceSystem>
          <name>Senate</name>
        </sourceSystem>
        <text>Received in the Senate and Read twice and referred to the Committee on Health, Education, Labor, and Pensions.</text>
        <type>IntroReferral</type>
      </item>
      <item>
        <actionDate>2020-09-21</actionDate>
        <actionTime>17:52:12</actionTime>
        <text>Motion to reconsider laid on the table Agreed to without objection.</text>
        <type>Floor</type>
        <actionCode>H38310</actionCode>
        <sourceSystem>
          <code>2</code>
          <name>House floor actions</name>
        </sourceSystem>
      </item>
      <item>
        <actionDate>2020-09-21</actionDate>
        <actionTime>17:52:09</actionTime>
        <text>On motion to suspend the rules and pass the bill, as amended Agreed to by voice vote. (text: CR H4616-4617)</text>
        <type>Floor</type>
        <actionCode>H37300</actionCode>
        <sourceSystem>
          <code>2</code>
          <name>House floor actions</name>
        </sourceSystem>
      </item>
      <item>
        <actionDate>2020-09-21</actionDate>
        <actionTime>17:52:09</actionTime>
        <text>Passed/agreed to in House: On motion to suspend the rules and pass the bill, as amended Agreed to by voice vote.</text>
        <type>Floor</type>
        <actionCode>8000</actionCode>
        <sourceSystem>
          <code>9</code>
          <name>Library of Congress</name>
        </sourceSystem>
      </item>
      <item>
        <actionDate>2020-09-21</actionDate>
        <actionTime>17:43:35</actionTime>
        <text>DEBATE - The House proceeded with forty minutes of debate on H.R. 4866.</text>
        <type>Floor</type>
        <actionCode>H8D000</actionCode>
        <sourceSystem>
          <code>2</code>
          <name>House floor actions</name>
        </sourceSystem>
      </item>
      <item>
        <actionDate>2020-09-21</actionDate>
        <actionTime>17:43:33</actionTime>
        <text>Considered under suspension of the rules. (consideration: CR H4616-4618)</text>
        <type>Floor</type>
        <actionCode>H30000</actionCode>
        <sourceSystem>
          <code>2</code>
          <name>House floor actions</name>
        </sourceSystem>
      </item>
      <item>
        <actionDate>2020-09-21</actionDate>
        <actionTime>17:43:20</actionTime>
        <text>Mrs. Dingell moved to suspend the rules and pass the bill, as amended.</text>
        <type>Floor</type>
        <actionCode>H30300</actionCode>
        <sourceSystem>
          <code>2</code>
          <name>House floor actions</name>
        </sourceSystem>
      </item>
      <item>
        <actionDate>2020-09-17</actionDate>
        <text>Placed on the Union Calendar, Calendar No. 413.</text>
        <type>Calendars</type>
        <actionCode>H12410</actionCode>
        <sourceSystem>
          <code>2</code>
          <name>House floor actions</name>
        </sourceSystem>
        <calendarNumber>
          <calendar>U00413</calendar>
        </calendarNumber>
      </item>
      <item>
        <actionDate>2020-09-17</actionDate>
        <text>Reported (Amended) by the Committee on Energy and Commerce. H. Rept. 116-513.</text>
        <type>Committee</type>
        <actionCode>H12200</actionCode>
        <sourceSystem>
          <code>2</code>
          <name>House floor actions</name>
        </sourceSystem>
        <committees>
          <item>
            <systemCode>hsif00</systemCode>
            <name>Energy and Commerce Committee</name>
          </item>
        </committees>
      </item>
      <item>
        <actionDate>2020-09-17</actionDate>
        <text>Reported (Amended) by the Committee on Energy and Commerce. H. Rept. 116-513.</text>
        <type>Committee</type>
        <actionCode>5000</actionCode>
        <sourceSystem>
          <code>9</code>
          <name>Library of Congress</name>
        </sourceSystem>
        <committees>
          <item>
            <systemCode>hsif00</systemCode>
            <name>Energy and Commerce Committee</name>
          </item>
        </committees>
      </item>
      <item>
        <actionDate>2020-07-15</actionDate>
        <committees>
          <item>
            <systemCode>hsif00</systemCode>
            <name>Energy and Commerce Committee</name>
          </item>
        </committees>
        <sourceSystem>
          <code>1</code>
          <name>House committee actions</name>
        </sourceSystem>
        <text>Ordered to be Reported (Amended) by Voice Vote.</text>
        <type>Committee</type>
      </item>
      <item>
        <actionDate>2020-07-15</actionDate>
        <committees>
          <item>
            <systemCode>hsif00</systemCode>
            <name>Energy and Commerce Committee</name>
          </item>
        </committees>
        <sourceSystem>
          <code>1</code>
          <name>House committee actions</name>
        </sourceSystem>
        <text>Committee Consideration and Mark-up Session Held.</text>
        <type>Committee</type>
      </item>
      <item>
        <actionDate>2020-03-11</actionDate>
        <committees>
          <item>
            <systemCode>hsif14</systemCode>
            <name>Health Subcommittee</name>
          </item>
        </committees>
        <sourceSystem>
          <code>1</code>
          <name>House committee actions</name>
        </sourceSystem>
        <text>Forwarded by Subcommittee to Full Committee (Amended) by Voice Vote .</text>
        <type>Committee</type>
      </item>
      <item>
        <actionDate>2020-03-11</actionDate>
        <committees>
          <item>
            <systemCode>hsif14</systemCode>
            <name>Health Subcommittee</name>
          </item>
        </committees>
        <sourceSystem>
          <code>1</code>
          <name>House committee actions</name>
        </sourceSystem>
        <text>Subcommittee Consideration and Mark-up Session Held.</text>
        <type>Committee</type>
      </item>
      <item>
        <actionDate>2019-10-29</actionDate>
        <committees>
          <item>
            <systemCode>hsif14</systemCode>
            <name>Health Subcommittee</name>
          </item>
        </committees>
        <sourceSystem>
          <code>1</code>
          <name>House committee actions</name>
        </sourceSystem>
        <text>Referred to the Subcommittee on Health.</text>
        <type>Committee</type>
      </item>
      <item>
        <actionDate>2019-10-28</actionDate>
        <text>Referred to the House Committee on Energy and Commerce.</text>
        <type>IntroReferral</type>
        <actionCode>H11100</actionCode>
        <sourceSystem>
          <code>2</code>
          <name>House floor actions</name>
        </sourceSystem>
        <committees>
          <item>
            <systemCode>hsif00</systemCode>
            <name>Energy and Commerce Committee</name>
          </item>
        </committees>
      </item>
      <item>
        <actionDate>2019-10-28</actionDate>
        <text>Introduced in House</text>
        <type>IntroReferral</type>
        <actionCode>Intro-H</actionCode>
        <sourceSystem>
          <code>9</code>
          <name>Library of Congress</name>
        </sourceSystem>
      </item>
      <item>
        <actionDate>2019-10-28</actionDate>
        <text>Introduced in House</text>
        <type>IntroReferral</type>
        <actionCode>1000</actionCode>
        <sourceSystem>
          <code>9</code>
          <name>Library of Congress</name>
        </sourceSystem>
      </item>
    </actions>
    <sponsors>
      <item>
        <bioguideId>P000034</bioguideId>
        <fullName>Rep. Pallone, Frank, Jr. [D-NJ-6]</fullName>
        <firstName>FRANK</firstName>
        <lastName>PALLONE</lastName>
        <party>D</party>
        <state>NJ</state>
        <district>6</district>
        <isByRequest>N</isByRequest>
      </item>
    </sponsors>
    <cosponsors>
      <item>
        <bioguideId>G000558</bioguideId>
        <fullName>Rep. Guthrie, Brett [R-KY-2]</fullName>
        <firstName>Brett</firstName>
        <lastName>Guthrie</lastName>
        <party>R</party>
        <state>KY</state>
        <district>2</district>
        <sponsorshipDate>2019-10-28</sponsorshipDate>
        <isOriginalCosponsor>True</isOriginalCosponsor>
      </item>
      <item>
        <bioguideId>S001209</bioguideId>
        <fullName>Rep. Spanberger, Abigail Davis [D-VA-7]</fullName>
        <firstName>Abigail</firstName>
        <lastName>Spanberger</lastName>
        <party>D</party>
        <state>VA</state>
        <middleName>Davis</middleName>
        <district>7</district>
        <sponsorshipDate>2020-05-12</sponsorshipDate>
        <isOriginalCosponsor>False</isOriginalCosponsor>
      </item>
    </cosponsors>
    <cboCostEstimates>
      <item>
        <pubDate>2020-11-24T21:00:00Z</pubDate>
        <title>H.R. 4866, National Centers of Excellence in Continuous Pharmaceutical Manufacturing Act of 2020</title>
        <url>https://www.cbo.gov/publication/56798</url>
        <description>As passed by the House of Representatives on September 21, 2020</description>
      </item>
    </cboCostEstimates>
    <policyArea>
      <name>Health</name>
    </policyArea>
    <subjects>
      <legislativeSubjects>
        <item>
          <name>Advanced technology and technological innovations</name>
        </item>
        <item>
          <name>Congressional oversight</name>
        </item>
        <item>
          <name>Drug safety, medical device, and laboratory regulation</name>
        </item>
        <item>
          <name>Government information and archives</name>
        </item>
        <item>
          <name>Health programs administration and funding</name>
        </item>
        <item>
          <name>Health technology, devices, supplies</name>
        </item>
        <item>
          <name>Higher education</name>
        </item>
        <item>
          <name>Manufacturing</name>
        </item>
        <item>
          <name>Prescription drugs</name>
        </item>
        <item>
          <name>Product development and innovation</name>
        </item>
        <item>
          <name>Research administration and funding</name>
        </item>
        <item>
          <name>Research and development</name>
        </item>
      </legislativeSubjects>
      <policyArea>
        <name>Health</name>
      </policyArea>
    </subjects>
    <summaries>
      <summary>
        <versionCode>00</versionCode>
        <actionDate>2019-10-28</actionDate>
        <actionDesc>Introduced in House</actionDesc>
        <updateDate>2021-09-10T13:35:54Z</updateDate>
        <text><![CDATA[ <p><b>National Centers of Excellence in Continuous Pharmaceutical Manufacturing Act of 2019</b></p> <p>This bill directs the Food and Drug Administration (FDA) to designate qualified institutions of higher education as National Centers of Excellence in Continuous Pharmaceutical Manufacturing and to provide grants to the centers. Each designated center must conduct research on continuous manufacturing technologies and must share information from such research with the FDA. (Currently, most drug production involves batch manufacturing, which typically takes longer than continuous manufacturing processes.)</p>]]></text>
      </summary>
      <summary>
        <versionCode>53</versionCode>
        <actionDate>2020-09-21</actionDate>
        <actionDesc>Passed House</actionDesc>
        <updateDate>2021-09-10T13:13:10Z</updateDate>
        <text><![CDATA[ <p><strong>National Centers of Excellence in Continuous Pharmaceutical Manufacturing Act of 2020</strong></p> <p>This bill directs the Food and Drug Administration (FDA) to designate qualified institutions of higher education as National Centers of Excellence in Continuous Pharmaceutical Manufacturing and to provide grants to the centers. Each designated center must conduct research on continuous manufacturing technologies and must share information from such research with the FDA. (Currently, most drug production involves batch manufacturing, which typically takes longer than continuous manufacturing processes.)</p> ]]></text>
      </summary>
    </summaries>
    <title>National Centers of Excellence in Continuous Pharmaceutical Manufacturing Act of 2020</title>
    <titles>
      <item>
        <titleType>Display Title</titleType>
        <title>National Centers of Excellence in Continuous Pharmaceutical Manufacturing Act of 2020</title>
      </item>
      <item>
        <titleType>Short Title(s) as Passed House</titleType>
        <title>National Centers of Excellence in Continuous Pharmaceutical Manufacturing Act of 2020</title>
        <chamberCode>H</chamberCode>
        <chamberName>House</chamberName>
        <billTextVersionName>Engrossed in House</billTextVersionName>
        <billTextVersionCode>EH</billTextVersionCode>
      </item>
      <item>
        <titleType>Official Title as Introduced</titleType>
        <title>To amend the 21st Century Cures Act to provide for designation of institutions of higher education that provide research, data, and leadership on continuous manufacturing as National Centers of Excellence in Continuous Pharmaceutical Manufacturing, and for other purposes.</title>
        <billTextVersionName>Reported in House</billTextVersionName>
        <billTextVersionCode>RH</billTextVersionCode>
      </item>
      <item>
        <titleType>Short Titles as Passed House</titleType>
        <title>National Centers of Excellence in Continuous Pharmaceutical Manufacturing Act of 2020</title>
        <chamberCode>H</chamberCode>
        <chamberName>House</chamberName>
      </item>
      <item>
        <titleType>Short Title(s) as Introduced</titleType>
        <title>National Centers of Excellence in Continuous Pharmaceutical Manufacturing Act of 2019</title>
        <billTextVersionName>Introduced in House</billTextVersionName>
        <billTextVersionCode>IH</billTextVersionCode>
      </item>
      <item>
        <titleType>Short Title(s) as Reported to House</titleType>
        <title>National Centers of Excellence in Continuous Pharmaceutical Manufacturing Act of 2020</title>
        <chamberCode>H</chamberCode>
        <chamberName>House</chamberName>
        <billTextVersionName>Reported in House</billTextVersionName>
        <billTextVersionCode>RH</billTextVersionCode>
      </item>
    </titles>
    <textVersions>
      <item>
        <type>Referred in Senate</type>
        <date>2020-09-22T04:00:00Z</date>
        <formats>
          <item>
            <url>https://www.govinfo.gov/content/pkg/BILLS-116hr4866rfs/xml/BILLS-116hr4866rfs.xml</url>
          </item>
        </formats>
      </item>
      <item>
        <type>Engrossed in House</type>
        <date>2020-09-21T04:00:00Z</date>
        <formats>
          <item>
            <url>https://www.govinfo.gov/content/pkg/BILLS-116hr4866eh/xml/BILLS-116hr4866eh.xml</url>
          </item>
        </formats>
      </item>
      <item>
        <type>Reported in House</type>
        <date>2020-09-17T04:00:00Z</date>
        <formats>
          <item>
            <url>https://www.govinfo.gov/content/pkg/BILLS-116hr4866rh/xml/BILLS-116hr4866rh.xml</url>
          </item>
        </formats>
      </item>
      <item>
        <type>Introduced in House</type>
        <date>2019-10-28T04:00:00Z</date>
        <formats>
          <item>
            <url>https://www.govinfo.gov/content/pkg/BILLS-116hr4866ih/xml/BILLS-116hr4866ih.xml</url>
          </item>
        </formats>
      </item>
    </textVersions>
    <latestAction>
      <actionDate>2020-09-22</actionDate>
      <text>Received in the Senate and Read twice and referred to the Committee on Health, Education, Labor, and Pensions.</text>
    </latestAction>
  </bill>
  <dublinCore xmlns:dc="http://purl.org/dc/elements/1.1/">
    <dc:format>text/xml</dc:format>
    <dc:language>EN</dc:language>
    <dc:rights>Pursuant to Title 17 Section 105 of the United States Code, this file is not subject to copyright protection and is in the public domain.</dc:rights>
    <dc:contributor>Congressional Research Service, Library of Congress</dc:contributor>
    <dc:description>This file contains bill summaries and statuses for federal legislation. A bill summary describes the most significant provisions of a piece of legislation and details the effects the legislative text may have on current law and federal programs. Bill summaries are authored by the Congressional Research Service (CRS) of the Library of Congress. As stated in Public Law 91-510 (2 USC 166 (d)(6)), one of the duties of CRS is "to prepare summaries and digests of bills and resolutions of a public general nature introduced in the Senate or House of Representatives". For more information, refer to the User Guide that accompanies this file.</dc:description>
  </dublinCore>
</billStatus>
